Home/ Supplements/ Omega 3/ CholestHealth

CholestHealth

product on market Softgel Capsule Sundown Naturals Safety: 97/100
97/100

This product looks safe

  • Niacin: 600mg is 17.1× the Tolerable Upper Intake Level (35mg)
  • 33% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of basic macronutrients rather than active therapeutic compounds. Consequently, there is limited research evidence to support specific health claims for this particular profile. The product maintains a high safety score, indicating a low risk of adverse effects.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 600mg is 17.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for CholestHealth
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
40
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 {Calories}
Total Fat
1.5 Gram(s) (2% DV)
Cholesterol
5 mg (2% DV)
Total Carbohydrates
1 Gram(s) (1% DV)
Protein
1 Gram(s) (2% DV)
600 mg (3000% DV)
Exceeds UL by 17.1× (UL: 35 mg) 196 studies (A:5, B:63)
Phytosterol Complex
975 mg
750 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Pantethine
37.5 mg
150 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Policosanol
7.5 mg

Other Ingredients

Gelatin Vegetable Glycerin Soybean Oil Contains Less Than 2% of
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Approved Health
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: FOR ADULTS, TAKE THREE (3) SOFTGELS DAILY WITH A MEAL.

Warnings & Precautions

Discontinue use and consult your doctor if any adverse reactions occur.

Contains soy and fish (anchovy, mackerel, sardine) ingredients.

WARNING: Not intended for use by pregnant or nursing women. If you are taking any medications, consult your doctor before use.

KEEP OUT OF REACH OF CHILDREN.

TAMPER RESISTANT: DO NOT USE IF SEAL UNDER CAP IS BROKEN OR MISSING.

Formulation Notes

Contains soy and fish (anchovy, mackerel, sardine) ingredients.

CholestHealth(TM) features important plant sterols such as Beta-Sitosterol and Stigmasterol, which support cholesterol levels already within a normal range.* CholestHealth(TM) is also formulated with beneficial ingredients, such as Omega-3 fatty acids for heart health.*

A serving of CholestHealth(TM) supplies 0.6 g of plant sterols.

No Artificial Flavor or Sweetener, No Sugar, No Starch, No Milk, No Lactose, No Gluten, No Wheat, No Yeast, No Shellfish. Sodium Free.

Additional Information

Cholesterol Support* ~ Helps Support Circulatory & Cardiovascular Health* ~ May Reduce the Risk of Heart Disease**

As a reminder, discuss the supplements and medications you take with your health care providers.

Prod. No. 17856 01B B17077 CAA

**Diets low in saturated fat and cholesterol that include 2 g per day of plant sterols eaten with meals or snacks may reduce the risk of heart disease.

STORE AT ROOM TEMPERATURE AND AVOID EXCESSIVE HEAT.

PLEASE RECYCLE

GUARANTEED LABORATORY TESTED QUALITY

Metadata

Product Details

UPC / SKU0 30768 17856 7
DSLD Entry Date2014-03-25
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID31571
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.